Financial burden of prostate cancer in the Iranian population: a cost of illness and financial risk protection analysis

被引：0
作者：
Farbod Alinezhad
Farhad Khalili
Hossein Zare
Chunling Lu
Zahra Mahmoudi
Mahmood Yousefi
机构：
[1] Bouvé College of Health Sciences,Management Development, Resources and Planning
[2] Northeastern University,Department of Health Policy and Management
[3] Guilan University of Medical Sciences,Division of Global Health Equity
[4] Johns Hopkins Bloomberg School of Public Health,Department of Global Health & Social Medicine
[5] Brigham & Women’s Hospital,Department of Health Economics, School of Management and Medical Informatics
[6] Harvard Medical School,Tabriz Health Services Management Research Center, Department of Health Economics, School of Management and Medical Informatics
[7] Tabriz University of Medical Sciences,undefined
[8] Tabriz University of Medical Sciences.,undefined
来源：
Cost Effectiveness and Resource Allocation | / 21卷
关键词：
Prostate cancer; Cost of illness; Prevalence-based; Health expenditures;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 122 条
[11]  
Piñeros M(2009)Cancer incidence and mortality rates in Bermuda West Indian Med J 58 367-4
[12]  
Almasi Z(2009)Cancer incidence in Ilam J Ilam Univ Med Sci 17 24-813
[13]  
Mohammadian-Hafshejani A(1992)Cost-of-illness studies Pharmacoeconomics 2 1-440
[14]  
Salehiniya H(2011)The economic burden of prostate cancer BJU Int 108 806-1300
[15]  
Einsiedel L(1967)Estimating the cost of illness Am J Public Health Nation's Health 57 424-1520
[16]  
Fernandes L(1982)The priceless value of human life Am J Public Health 72 1299-179
[17]  
Joseph S(1985)The economic costs of illness: a replication and update Health Care Financing Rev 7 61-63
[18]  
Brown A(1994)Cost-of-illness studies: fact or fiction? Lancet 344 1519-495
[19]  
Woodman RJ(2000)Cost of illness studies: what is good about them? Inj Prev 6 177-302
[20]  
Omran A(2006)Cost-of-illness analysis: what room in health economics? Health Policy 77 51-10
12345678910